wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q35008618-329C8FAA-25AC-4ECE-8EB4-A76F96E05FF5
Q35008618-329C8FAA-25AC-4ECE-8EB4-A76F96E05FF5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35008618-329C8FAA-25AC-4ECE-8EB4-A76F96E05FF5
Safety of bosutinib versus imatinib in the phase 3 BELA trial in newly diagnosed chronic phase chronic myeloid leukemia.
P2860
Q35008618-329C8FAA-25AC-4ECE-8EB4-A76F96E05FF5
BestRank
Statement
http://www.wikidata.org/entity/statement/Q35008618-329C8FAA-25AC-4ECE-8EB4-A76F96E05FF5
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
7c95fad5ac500ecaa2554dfdacc6589c0d0b8fdf
P2860
In vitro and in vivo activity of SKI-606, a novel Src-Abl inhibitor, against imatinib-resistant Bcr-Abl+ neoplastic cells.